Sign inJoin waitlistJoin the waitlist

Siwen Hu-Lieskovan

Physician · University of Utah School of Medicine

Credentials: · · · · ·

History

University of Utah School of Medicine
2019–Present

Huntsman Cancer Institute & Hospital
2017–2019
Internal Medicine
2014–2017
David Geffen Sch of Med at UCLA
2010–2014

Research

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Review · Cell · 2017 · 4,507 citations
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine · 2016 · 2,646 citations
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports · 2017 · 1,523 citations

Antoni Ribas
30 papers
Bartosz Chmielowski
11 papers
JZ
Jesse Zaretsky
10 papers · 3 as a resident
John Hyngstrom
9 papers
Jennifer Keihner
8 papers
Jeffrey Sosman
7 papers
KK
Kari Kendra
7 papers
KG
Kenneth Grossmann
7 papers
Umang Swami
7 papers
Douglas Johnson
6 papers
Sapna Patel
6 papers
Timothy Triche
6 papers

Clinical trials

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Principal investigator · Recruiting · Phase 2
University of Utah
2026–2030
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2027
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2018–2026